For this model, we used NHF1 cells engineered to constitutively secrete TRAIL, a protein that binds to death receptors on GBM cells to induce apoptosis,38 against LN229, an established GBM tumor line that exhibits diffuse behavior in vivo (Figure 6a).39 The gene discussed is TNFSF10; the disease is neoplasm.